A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...
This drug has the potential to be more targeted than others currently being studied, and we hope it will result in fewer ...
Researchers make promising breakthrough in Alzheimer’s drug development: Lancaster Monday, October 7, 2024, 11:00 Hrs [IST] An international team of researchers led by Lancaster ...
A breast cancer diagnosis is particularly problematic — yet possible — for women caregivers, columnist Ray Burow writes.
Find out how to measure the experience of people with dementia when commissioning, improving or creating new services and products, whether big or small. This resource was developed with people ...